HB1126
To Expand The List Of Medications For Conditions Or Treatments That Are Not Counted Towards The Prescription Benefit Cap Within The Arkansas Medicaid Program.
Last Action (May 1, 2023): Died in House Committee at Sine Die Adjournment
Sponsors
AI-Generated Summary
House Bill 1126 seeks to amend Arkansas Code § 20-77-406(c) to modify the prescription benefit limitations within the Arkansas Medicaid program. Currently, the program limits the number of prescriptions an adult beneficiary can receive per month. The bill adds anti-seizure medications and psychotropic medications to the list of medications that are exempt from counting toward this monthly prescription cap. By excluding these specific classes of drugs, the legislation aims to ensure that Medicaid recipients managing epilepsy or mental health conditions can access necessary treatments without hitting their monthly allotment limit. The bill represents an expansion of existing exemptions meant to prioritize critical health maintenance medications.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries are adult Arkansas Medicaid recipients who suffer from epilepsy or chronic mental health conditions. These individuals will benefit from increased access to prescribed medications without the risk of reaching their monthly benefit cap, thereby ensuring continuity of care and better health management.
Who Might Suffer?
The primary entity negatively impacted is the Arkansas state budget, specifically the Department of Human Services, which will likely face increased expenditures as the program covers a higher volume of prescriptions that were previously capped. Additionally, taxpayers may be indirectly impacted due to the increased fiscal demand on the state's Medicaid funding.
Get Notified
Receive an email when this bill's status changes.